Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunohistochemistry as an accurate tool for the assessment of BRAF V600E and TP53 mutations in primary and metastatic melanoma.
Rusu S, Verocq C, Trepant AL, Maris C, De Nève N, Blanchard O, Van Campenhout C, De Clercq S, Rorive S, Cotoi OS, Decaestecker C, Salmon I, D'Haene N. Rusu S, et al. Among authors: de neve n, de clercq s. Mol Clin Oncol. 2021 Dec;15(6):270. doi: 10.3892/mco.2021.2432. Epub 2021 Nov 1. Mol Clin Oncol. 2021. PMID: 34790354 Free PMC article.
4-IBP, a sigma1 receptor agonist, decreases the migration of human cancer cells, including glioblastoma cells, in vitro and sensitizes them in vitro and in vivo to cytotoxic insults of proapoptotic and proautophagic drugs.
Mégalizzi V, Mathieu V, Mijatovic T, Gailly P, Debeir O, De Neve N, Van Damme M, Bontempi G, Haibe-Kains B, Decaestecker C, Kondo Y, Kiss R, Lefranc F. Mégalizzi V, et al. Among authors: de neve n. Neoplasia. 2007 May;9(5):358-69. doi: 10.1593/neo.07130. Neoplasia. 2007. PMID: 17534441 Free PMC article.
Nucleolus and c-Myc: potential targets of cardenolide-mediated antitumor activity.
Mijatovic T, De Nève N, Gailly P, Mathieu V, Haibe-Kains B, Bontempi G, Lapeira J, Decaestecker C, Facchini V, Kiss R. Mijatovic T, et al. Among authors: de neve n. Mol Cancer Ther. 2008 May;7(5):1285-96. doi: 10.1158/1535-7163.MCT-07-2241. Mol Cancer Ther. 2008. PMID: 18483316 Free article.
A simplified approach for the molecular classification of glioblastomas.
Le Mercier M, Hastir D, Moles Lopez X, De Nève N, Maris C, Trepant AL, Rorive S, Decaestecker C, Salmon I. Le Mercier M, et al. Among authors: de neve n. PLoS One. 2012;7(9):e45475. doi: 10.1371/journal.pone.0045475. Epub 2012 Sep 18. PLoS One. 2012. PMID: 23029035 Free PMC article.
Clinical Validation of Targeted Next Generation Sequencing for Colon and Lung Cancers.
D'Haene N, Le Mercier M, De Nève N, Blanchard O, Delaunoy M, El Housni H, Dessars B, Heimann P, Remmelink M, Demetter P, Tejpar S, Salmon I. D'Haene N, et al. Among authors: de neve n. PLoS One. 2015 Sep 14;10(9):e0138245. doi: 10.1371/journal.pone.0138245. eCollection 2015. PLoS One. 2015. PMID: 26366557 Free PMC article. Clinical Trial.
[Next generation sequencing].
Le Mercier M, D'Haene N, Rorive S, Degand C, De Nève N, Blanchard O, Salmon I. Le Mercier M, et al. Among authors: de neve n. Rev Med Brux. 2016;37(5):436-438. Rev Med Brux. 2016. PMID: 28525213 French.
59 results